» Articles » PMID: 30446840

Resected Thymic Large Cell Neuroendocrine Carcinoma: Report of a Case

Abstract

Background: Thymic large cell neuroendocrine carcinoma (LCNEC) is extremely rare. The detailed clinical features of thymic LNCECs remain unknown.

Case Presentation: A 90-year-old man with a history of diabetes mellitus, chronic renal failure, and an abdominal aortic aneurysm underwent computed tomography for follow-up, which showed an anterior mediastinal tumor, measuring 31 mm × 28 mm in diameter. Magnetic resonance imaging showed an iso-intensity mass on T1-weighted images and high intensity on T2-weighted images. 18F-Fluorodeoxyglucose-positron emission tomography showed marked uptake in the mass, which was diagnosed as invasive thymoma or thymic carcinoma. Video-assisted thoracic surgery through the left thoracic cavity was converted to median sternotomy due to severe adhesions between the left lung and the chest wall. Partial thymectomy and combined partial resection of left upper lobectomy and the first and the second costal cartilages were performed. The pathologic diagnosis was thymic LCNEC, Masaoka stage III. The patient developed pleural dissemination and left lung metastases in 5 months and died 12 months after surgery.

Conclusions: Thymic LCNEC has high malignant potential. More cases need to be studied.

Citing Articles

MRI Findings and Differential Diagnosis of Anterior Mediastinal Solid Tumors.

Nakazono T, Yamaguchi K, Egashira R, Iyadomi M, Fujiki K, Takayanagi S Magn Reson Med Sci. 2022; 22(4):415-433.

PMID: 35296589 PMC: 10552663. DOI: 10.2463/mrms.rev.2021-0098.


Resected thymic large cell neuroendocrine carcinoma: A case report and review of the literature.

Ogata S, Maeda R, Tomita M, Sato Y, Ayabe T, Nakamura K Int J Surg Case Rep. 2019; 60:53-57.

PMID: 31202999 PMC: 6580310. DOI: 10.1016/j.ijscr.2019.05.057.

References
1.
Kriegsmann M, Muley T, Harms A, Tavernar L, Goldmann T, Dienemann H . Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: a large scale study of 1465 non-small cell lung cancer cases. Diagn Pathol. 2015; 10:210. PMC: 4672573. DOI: 10.1186/s13000-015-0441-7. View

2.
Cardillo G, Rea F, Lucchi M, Paul M, Margaritora S, Carleo F . Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients. Ann Thorac Surg. 2012; 94(1):241-5. DOI: 10.1016/j.athoracsur.2012.03.062. View

3.
Dorfman D, Shahsafaei A, Chan J . Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity. Am J Surg Pathol. 1997; 21(8):936-40. DOI: 10.1097/00000478-199708000-00008. View

4.
Mega S, Oguri M, Kawasaki R, Hazama K, Iwai K, Kondo S . Large-cell neuroendocrine carcinoma in the thymus. Gen Thorac Cardiovasc Surg. 2008; 56(11):566-9. DOI: 10.1007/s11748-008-0299-7. View

5.
Nagata Y, Ohno K, Utsumi T, Sasaki Y, Suzuki Y . Large cell neuroendocrine thymic carcinoma coexisting within large WHO type AB thymoma. Jpn J Thorac Cardiovasc Surg. 2006; 54(6):256-9. DOI: 10.1007/pl00022248. View